XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income (Loss) Per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Net Income (Loss) Per Share NET INCOME (LOSS) PER SHARE
The calculation of net income (loss) per common share including the number of shares for both basic and diluted net income (loss) per share is as follows (in thousands, except share and per share data):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Basic weighted average number of common shares outstanding18,324,534 17,578,653 18,256,587 17,202,631 
Dilutive securities (1),(2)
272,074 — 
Total shares including dilutive securities18,596,608 17,578,653 18,256,587 17,202,631 
Net income (loss) from continuing operations$1,024 $(4,581)$(1,410)$(5,326)
Loss from discontinued operations, net of tax(1,301)(44)(1,441)(128)
Net loss$(277)$(4,625)$(2,851)$(5,454)
Basic income (loss) per common share:
Basic income (loss) per common share from continuing operations$0.06 $(0.26)$(0.08)$(0.31)
Basic loss per common share from discontinued operations(0.07)— (0.08)(0.01)
Basic net loss per common share(0.02)(0.26)(0.16)(0.32)
.
Diluted income (loss) per common share:
Diluted income (loss) per common share from continuing operations$0.06 $(0.26)$(0.08)$(0.31)
Diluted loss per common share from discontinued operations(0.07)— (0.08)(0.01)
Diluted net loss per common share(0.01)(0.26)(0.16)(0.32)
_______________
(1)Dilutive securities include shares of unvested RSUs and stock options with exercise prices below the share price (in-the-money options) at September 30, 2022. The number of dilutive stock options is calculated under the treasury stock method which assumes proceeds received from the exercise of the options would be used to buy back shares of the Company's common stock at the market price. Excluded from the number of dilutive shares are 600,391 in-the-money options that could be repurchased under the treasury method and 1,300,000 options, with exercise prices in excess of the market price (out-of -the-money options) at September 30, 2022.
(2)The Company had no dilutive securities for the three months ended September 30, 2021 or for the nine months ended September 30, 2022 and 2021 since the Company incurred net losses for both continuing and discontinued operations for these periods and inclusion would be antidilutive.